Hemostatic Factors as Risk Markers for Intracerebral Hemorrhage: A Prospective Incident Case-Referent Study

Stroke

Volumn 35, Issue 4, 2004, Pages 826-830

  Johansson, Lars ^a   Jansson, Jan Håkan ^a   Stegmayr, Birgitta ^b   Nilsson, Torbjörn K ^c   Hallmans, Göran ^b   Boman, Kurt ^a  

^a Skelleftea Hospital   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebral hemorrhage; Fibrinolysis; Risk factors; Thrombomodulin; Von Willebrand factor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SWEDEN; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 1842419391     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000119382.25543.2A     Document Type: Article

References (15)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project: 1981-86, 2: incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990;53:16-22.
2. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage: Melbourne Risk Factor Study Group. Hypertension. 1998;31:1223-1229.
3. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34:2060-2065.
4. Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke. 2000;31:26-32.
5. Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G. Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischemic and hemorrhagic stroke. Thromb Haemost. 2002;87:211-217.
6. Weinehall L, Johnson O, Jansson JH, Boman K, Huhtasaari F, Hallmans G, Dahlen GH, Wall S. Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction: an incident case-control study from northern Sweden. J Intern Med. 1998;243:99-107.
7. Tunstall-Pedoe H. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration: WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41:105-114.
8. Stegmayr B, Asplund K, Wester PO. Trends in incidence, case-fatality rate, and severity of stroke in northern Sweden, 1985-1991. Stroke. 1994;25:1738-1745.
9. Nordenhem A, Wiman B. Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes. Scand J Clin Lab Invest. 1998;58:475-483.
10. Amiral J, Adam M, Mimilla F, Larrivaz I, Chambrette B, Boffa MC. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. Hybridoma. 1994;13:205-213.
11. Cejka J. Enzyme immunoassay for factor VIII-related antigen. Clin Chem. 1982;28:1356-1358.
12. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467-470.
13. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452-456.
14. Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1997;17:3321-3325.
15. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension: Melbourne Risk Factor Study (MERFS) Group. Stroke. 1996;27:2020-2025.